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he conserved oligomeric Golgi (COG) complex is
an evolutionarily conserved multi-subunit protein
complex that regulates membrane trafﬁcking in eu-
karyotic cells. In this work we used short interfering RNA
strategy to achieve an efﬁcient knockdown (KD) of Cog3p
in HeLa cells. For the ﬁrst time, we have demonstrated that
Cog3p depletion is accompanied by reduction in Cog1,
2, and 4 protein levels and by accumulation of COG
complex-dependent (CCD) vesicles carrying v-SNAREs
GS15 and GS28 and cis-Golgi glycoprotein GPP130.
Some of these CCD vesicles appeared to be vesicular coat
T
 
complex I (COPI) coated. A prolonged block in CCD vesi-
cles tethering is accompanied by extensive fragmentation
of the Golgi ribbon. Fragmented Golgi membranes main-
tained their juxtanuclear localization, cisternal organiza-
tion and are competent for the anterograde trafﬁcking of
vesicular stomatitis virus G protein to the plasma mem-
brane. In a contrast, Cog3p KD resulted in inhibition of
retrograde trafﬁcking of the Shiga toxin. Furthermore, the
mammalian COG complex physically interacts with GS28
and COPI and speciﬁcally binds to isolated CCD vesicles.
 
Introduction
 
The Golgi apparatus is a hub for membrane trafficking path-
ways, organizing both the anterograde exocytic trafficking of
newly synthesized proteins that travel from the ER to the
plasma membrane and retrograde endocytic trafficking of cell
surface molecules that travel back to the ER (for review see
Shorter and Warren, 2002). COP I coat proteins function in
intra-Golgi trafficking and in maintaining the normal structure
of the Golgi complex (Duden, 2003). We and others have pre-
viously shown that the Golgi vesicular coat complex I (COPI)-
modulated membrane trafficking used conserved oligomeric
Golgi (COG) vesicle tethering complex (Ram et al., 2002;
Suvorova et al., 2002; Oka et al., 2004).
COG complex consists of eight subunits (COG1-8; Kings-
ley et al., 1986; Whyte and Munro, 2001; Suvorova et al., 2001,
2002; Ram et al., 2002; Ungar et al., 2002). A COG role in
Golgi membrane trafficking was suggested by biochemical
and genetic studies in yeast (VanRheenen et al., 1998, 1999;
Suvorova et al., 2002). Yeast COG complex interacts genetically
and physically with Rab protein Ypt1p, intra-Golgi SNARE
molecules, as well as with COPI (Suvorova et al., 2002).
Mutations in COG subunits disturb both structure and
function of the Golgi in eukaryotic cells (Podos et al., 1994;
Ram et al., 2002; Suvorova et al., 2002; Ungar et al., 2002;
Farkas et al., 2003), but the exact cellular function of the COG
complex remained elusive. It was recently shown that mamma-
lian cells that carried either deletion of COG1 and 2 or trun-
cated version of Cog7p are defective in Golgi glycosylation
(Wu et al., 2004) and maintain slightly dilated Golgi cisternae
with reduced levels of resident proteins GS15 and GS28 and
GPP130 (Oka et al., 2004). These mutant phenotypes may reflect
either the primary COG malfunction or secondary manifestations
that occur in cells after a prolonged adaptation period. Deletion
of either COG1 or COG2 in yeast cells is virtually incompati-
ble with membrane trafficking and normal cell growth (Van-
Rheenen et al., 1998; Ram et al., 2002), whereas 
 
 
 
COG1
 
 and
 
 
 
COG2
 
 CHO cells are not compromised in growth or protein
secretion. One possibility is that the primary COG deletion
phenotype in these cells is masked and/or suppressed by sec-
ondary mutations in cell genome. To better understand the
initial defects associated with the COG complex malfunction it
is important to acutely interfere with its activity. Transfection
with small interfering RNAs (siRNAs) and microinjection with
inhibitory antibodies are two efficient methods for acute protein
knockdown (KD) in mammalian cells.
We rationalized that the most evolutionary conserved
COG subunit would be the best candidate for the KD. Yeast
and mammalian Cog1 and Cog2 proteins do not share significant
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similarities, whereas the protein sequence of yeast Cog3p is
41% similar to mammalian Cog3p (Suvorova et al., 2001). In
this work, we used siRNA strategy for the efficient KD Cog3p
in HeLa cells. Cog3p depletion is accompanied by reduction in
Cog1, 2, and 4 protein levels and rapid accumulation of intra-
cellular vesicles carrying v-SNAREs GS15 and GS28 and cis-
Golgi glycoprotein GPP130. A prolonged COG3 KD induced
extensive Golgi fragmentation. Fragmented Golgi membranes
were deficient in retrograde trafficking of the Shiga toxin. Na-
tive immunoprecipitations (IPs) revealed that the COG com-
plex physically interacts with Golgi SNARE molecules and
COPI and specifically binds to isolated GPP130-containing
vesicles in vitro. For the first time, we have demonstrated that
the acute depletion of the mammalian COG complex results in
specific inhibition of tethering of retrograde vesicles and that
the efficient targeting of these vesicles is essential for the main-
tenance of the Golgi structure.
 
Results
 
Cog3p KD induces Golgi fragmentation
 
To interfere with the COG complex function in HeLa cells we
depleted Cog3p by using RNA interference technique (Elbashir
et al., 2001). Three different COG3-specific RNA duplexes
were tested initially and one of them (sense, AGACUUGUG-
CAGUUUAACA) efficiently induced reduction of the Cog3
protein level (Fig. 1 A). The expression of other lobe A COG
subunits Cog1p, Cog2p, and Cog4p was also reduced 72 h after
COG3 KD, whereas protein level of the lobe B Cog5-8p sub-
units remained unchanged. Similarly, cellular levels were
unchanged for other tested cell proteins: protein disulphide
isomerase (PDI), actin, GS28, syntaxin 5, GPP130, and p115
(Fig. 1 and unpublished data). Cell transfection with a nonspe-
cific siRNA did not change the levels of COG subunits expres-
sion (unpublished data).
Because the level of the lobe B COG subunits was not af-
fected by the Cog3p depletion we have determined their in-
tracellular localization by both immunofluorescence (IF) and
Western blot (WB) assays. We have found that significant
amounts of both Cog5p and Cog8p were still associated with
the membrane fraction (Fig. 1 B). IF analysis of COG3 KD
cells revealed that Cog6p (Fig. 1 C) and other lobe B subunits
(unpublished data) were localized on large structures in juxta-
nuclear region that were colocalized with resident Golgi en-
zyme GFP-tagged 
 
 
 
 1,4-galactosyltransferase (GalT-GFP; Fig.
1 C). Detailed analysis of COG3 KD cells revealed that both
GalT-GFP and a Golgi tethering factor GM130 were found on
fragmented Golgi membranes (Fig. 2).
To test the specificity of COG3 siRNA KD, we took ad-
vantage of the fact that human and mouse Cog3 proteins show
95% identity and, therefore, most likely would functionally
substitute each other. In the same time, human and mouse
COG3 siRNA target region share only 74% of homology with
five miss-matched nucleotides (Fig. 3 A) and this difference
can be used in gene-replacement siRNA experiments (Puthen-
veedu and Linstedt, 2004). In good agreement with our pre-
diction, in HeLa cells, that were cotransfected with both
hCOG3 siRNA and the plasmid that expressed mouse Cog3p,
Figure 1. SiRNA-induced COG3 KD is destabilizing Lobe
A COG complex subunits. (A) Expression of COG sub-
units after COG3 KD. WB of cell lysates from control and
COG3 KD cells. Average levels of the COG subunits
( SD, n   4) after 72 h of COG3 KD were determined
by quantitative WB, and normalized to mock-transfected
cells. (B) Membrane localization of COG complex sub-
units. WB of membrane (P100) and cytosol (S100) frac-
tions. (C) Cog6p localization. Control and COG3 KD
cells that stably express GalT-GFP were fixed and ana-
lyzed by three-color IF microscopy after immunostaining
with anti-Cog6p. DNA was stained with DAPI. Arrows
indicate Golgi or Golgi fragments. Bars, 10  m. 
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the Golgi fragmentation was completely or partially pre-
vented (Fig. 3 B). Similar results were obtained when cells
were transfected with mCOG3-containing vector 24 h after
hCOG3 siRNA transfection (unpublished data). We concluded
that the COG3 KD is specific and that the Cog3p depletion di-
rectly induces a reversible Golgi fragmentation.
To independently confirm an essential role for the COG
complex in Golgi structure maintenance, we used affinity-
purified antibodies against Cog3p (Suvorova et al., 2001).
These antibodies were previously used for both IF and IP of
the endogenous COG complex in mammalian cells (Suvorova
et al., 2001; Ungar et al., 2002). We rationalized that upon
microinjection into cells anti-Cog3p IgGs would specifically
bind to the Cog3p and interfere with the COG complex func-
tion. Indeed, we have observed that 4 h after the antibodies
microinjection the Golgi ribbon structure was converted into
multiple mostly juxtanuclear localized small fragments
(Fig. 4). This Golgi phenotype was persistent for up to 20 h
after antibody microinjection without any visible signs of cell
death. Microinjection with control antibodies did not change
the morphology of the Golgi (unpublished data). We have
concluded that anti-Cog3p antibodies like the COG3 siRNA
act by blocking Cog3p function, which is necessary for the
Golgi structure maintenance.
 
Loss of Cog3p expression results in 
accumulation of Golgi v-SNAREs and cis-
Golgi resident protein GPP130 in 
nontethered vesicles
 
Detailed IF analysis of different Golgi resident proteins in
COG3 KD cells revealed that the majority of integral and pe-
ripheral membrane Golgi proteins, including cis-Golgi tether-
ing factors p115 (Nelson et al., 1998) and GM130 (Nakamura
et al., 1995), cis-Golgi t-SNARE syntaxin 5 (Hay et al., 1998),
 
cis/medial
 
 Golgi tethering protein giantin (Linstedt and Hauri,
1993), and trans-Golgi tether p230 (Brown et al., 2001), were
present almost exclusively on relatively large (1–3 
 
 
 
m in size)
fragmented Golgi membranes (Fig. 5 A; unpublished data).
Figure 2. Cog3p depletion induces Golgi fragmentation. GalT-GFP HeLa
cells were transfected with COG3 siRNA (right column) or mock trans-
fected (left column). 72 h after transfection, cells were fixed and pro-
cessed for IF with anti-Cog3p (COG3p row), and anti-GM130 (GM130
row) antibodies. The bottom row represent merged three-color images.
Bars, 10  m.
Figure 3. Mouse COG3p expression partially
suppresses hCOG3 KD-induced Golgi frag-
mentation. (A) DNA alignment of a portion of
the hCOG3 and mCOG3 sequences. siRNA
target region is highlighted in the box. (B)
GalT-GFP HeLa cells were either mock trans-
fected (control), transfected with COG3 siRNA
(COG3 KD), or simultaneously transfected with
COG3p siRNA and mCOG3-encoding plas-
mid (COG3 KD  mCOG3) and imaged 72 h
after transfection. Bar, 10  m. 
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Surprisingly, we have found that a subset of Golgi proteins,
intra-Golgi v-SNAREs GS15 (Xu et al., 2002) and GS28 (Hay
et al., 1998), and cis-Golgi phosphoprotein GPP130 (Linstedt
et al., 1997) were localized preferentially to multiple small ves-
icle-like structures distributed throughout the cytoplasm of
Cog3p KD cells (Fig. 5 B). In control cells all these three pro-
teins were primarily localized to a juxtanuclear Golgi.
Small GPP130-positive structures in COG3 KD cells pre-
sumably represent nontethered vesicles, because, in cells perme-
abilized with the mild detergent digitonin, these structures were
efficiently washed away from cells, whereas large Golgi cisternae
remained inside the cells (Fig. 6 A). Similar digitonin sensitivity
was previously observed for Golgi-derived vesicles that are tran-
siently accumulated during mitosis (Jesch and Linstedt, 1998).
To verify our IF findings we performed a subcellular
fractionation of both COG3 KD and mock-treated HeLa cells
(Fig. 6 B). We have found that in COG3 KD cells 
 
 
 
50% of
both GPP130 and GS28 proteins are present in a 10K superna-
tant, whereas in lysates obtained from control cells these pro-
teins are almost exclusively cofractionated with large mem-
branes. Noticeably, the long syntaxin 5 isoform and the ER
resident protein PDI did not significantly change their subcel-
lular distribution in a COG3 KD cells.
To characterize membranes in 10K supernatant we have
first used gel-filtration analysis on a Sephacryl S-1000 column
(Fig. 6 C). This analysis revealed that in COG3 KD cells the
peak of GPP130 was eluted in fractions 11 and 12, whereas in
control cells GPP130 was mostly found in fractions 9 and 10.
We have concluded that in COG3 KD cells the GPP130 was
mostly associated with small vesicles.
To test GPP130 localization by another separation tech-
nique we used a glycerol velocity gradient. Post-nuclear super-
natant (PNS) from COG3 KD cells was loaded on 10–30%
glycerol gradient and membranes were separated by size (Fig.
6 D). WB analysis of collected fractions revealed that majority
of GPP130 signal was peaked in a vesicular fraction 3, whereas
large ER membranes (PDI lane) were concentrated at the bot-
tom of the gradient. A small fraction (
 
 
 
25%) of GPP130 was
also found at the bottom of the gradient and may represent a
fraction of the protein that was associated with large Golgi
fragments or vesicle aggregates. Because these vesicles were
accumulated as a result of Cog3p depletion, we have named
them a COG complex-dependent (CCD) vesicles. GPP130-
containing Golgi membranes from identically fractionated con-
trol cells were rapidly pelleted to the bottom of the glycerol
gradient (Jesch and Linstedt, 1998; unpublished data).
GPP130 is a heavily glycosylated cis-Golgi protein (Lin-
stedt et al., 1997) that cycles through trans-Golgi and endoso-
mal compartments (Puri et al., 2002) and rapidly degrades in
Figure 4. Microinjection of anti-Cog3 antibodies disrupts Golgi structure.
GalT-GFP HeLa cells were microinjected with anti-Cog3p IgGs and imaged
immediately (0 min) or 4 h (240 min) after the injection. Texas red was
used as an injection marker. Note that in cells injected with anti-Cog3 IgGs
Golgi (labeled with asterisks) become fragmented. Microinjections with the
preimmune IgGs did not result in Golgi fragmentation (date not depicted).
Figure 5. COG3 KD results in accumulation of multiple
vesicles that carry v-SNAREs GS15, GS28, and cis-Golgi
recycling protein GPP130. Control and COG3 KD cells
were fixed 72 h after transfection and analyzed by IF using
primary antibodies to indicated proteins and appropriate
Alexa 488– and Alexa 595–conjugated secondary anti-
bodies. (A) cis-Golgi tether p115, cis/medial Golgi
marker giantin, and trans-Golgi tether p230 are present
almost exclusively on Golgi ribbon in control cells and on
fragmented juxtanuclear Golgi membranes in COG3 KD
cells. (B) v-SNAREs GS15, GS28, and cis-Golgi marker
GPP130 are Golgi located in control cells and predomi-
nantly localized on multiple small structures distributed
throughout the COG3 KD cells. Bars, 10  m. 
COG COMPLEX IN INTRA-GOLGI TRAFFICKING • ZOLOV AND LUPASHIN
 
751
 
both 
 
 
 
COG1
 
 and 
 
 
 
COG2
 
 CHO cell lines (Oka et al., 2004).
We have found that both the protein level and the electro-
phoretic mobility of GPP130 were identical in both control and
COG3-KD cells. Therefore, it can be concluded that in HeLa
cells acute Cog3p depletion did not, at least initially, result in
GPP130 down-regulation and did not alter its glycosylation.
To further analyze the content of CCD vesicles we pre-
pared lysates from COG3 KD and control cells that stably ex-
press GFP-tagged 
 
N
 
-acetylgalactosaminyltransferase-2 (Gal-
NAc-T2). Both lysates were subjected to glycerol velocity
gradient centrifugation, membranes from vesicle peak fractions
3 and 4 were concentrated and relative concentrations of Golgi
and ER proteins were assessed by WB (Fig. 6 E). In an agree-
ment with our IF data, we have found that in COG3 KD cells
the amount of GPP130 in the CCD vesicle pool was increased
by approximately fourfold. The concentrations of two other
Golgi proteins, GS28 and GalNAc-T2-GFP were also increased
by approximately twofold, whereas the amount of ER marker
PDI remained unchanged. Small but detectable amounts of
GPP130, GS28, and GalNAc-T2 in vesicular fractions prepared
from control cells may represent a constitutive pool of recy-
cling vesicles.
We also tested whether accumulated CCD vesicles could
be recognized by the COG complex in vitro. The COG com-
plex was purified from HeLa cells that transiently express
YFP-Cog3p (Suvorova et al., 2001). Protein G–Agarose beads
loaded with the COG complex were incubated with PNS frac-
tion obtained from the COG3 KD cells. As a positive control
for vesicle binding we used beads loaded with anti-GS15 anti-
bodies and as a negative control for nonspecific binding we
used protein G–Agarose beads. As expected, anti-GS15 beads
efficiently pulled down GPP130-containing (Fig. 6 F, GS15
lane) and GS28-containing (unpublished data) vesicles. Im-
portantly, the COG beads were also capable to precipitate
GPP130-containing CCD vesicles (Fig. 6 F, compare lanes
COG and control). We have concluded that CCD vesicles may
directly bind to the COG complex and this interaction may be a
fist step in vesicle tethering to the cis-Golgi.
Results of the subcellular fractionation experiments con-
firmed the IF data that showed accumulation of CCD vesicles
in COG3 KD cells. It also raised an intriguing possibility that
not only recycling SNARE proteins and GPP130, but also
Golgi resident proteins like GalNAc-T2 may recycle in the
COG complex-dependent manner. To test this hypothesis, we
used HeLa cells that stably express VSV-tagged GalNAc-T2.
It was shown previously that unlike the GFP-tag the small
VSV-tag does not interfere with the GalNAc-T2 folding, func-
tion and localization (Storrie et al., 1998). Double IF labeling
experiments revealed that the vesicular pool of GalNAc-T2-
VSV increased significantly in COG3 KD cells (Fig. 6 G).
In the same time, vesicularization of GalNAc-T2–containing
Golgi region was not as dramatic as for GPP130-containing
membranes and only a few vesicular profiles were double la-
beled with both Golgi markers. This may reflect different ki-
netics of GPP130 and GalNAc-T2 recycling as well as a possi-
bility that different Golgi proteins may cycle in different
membrane carries.
Does accumulation of CCD vesicles occur before or after
COG3 KD-induced Golgi fragmentation? To answer this ques-
tion we analyzed COG3 KD cells every 12 h after the initial
COG3 siRNA transfection. We have found that 48 h after
transfection both GS15 (Fig. 7) and GPP130 (unpublished
data) were mostly found in CCD vesicles, whereas overall
Golgi structure labeled with GalT-GFP has not yet been dis-
turbed in a subpopulation of the COG3 KD cells. These data
support the idea that accumulation of CCD vesicles may occur
independently and before the Golgi fragmentation.
 
Fragmented Golgi membranes are 
capable in supporting anterograde but 
not retrograde protein trafficking
 
Although siRNA-induced COG3 KD induced both accumula-
tion of CCD vesicles and Golgi fragmentation, cells were able
to multiply and their growth rate was not severely affected
(unpublished data). Moreover, fragmented Golgi membranes
maintained their juxtanuclear localization (Fig. 5 A). Detailed
IF analysis revealed that cis-Golgi p115 (Nelson et al., 1998),
and the medial Golgi GalNAc-T2 (Storrie et al., 1998), main-
tained their overlapping but distinct distribution on both con-
trol Golgi ribbon-like structure and Golgi fragments in COG3
KD cells (Fig. 8 A, GalNacT2/p115 frames). Similarly, local-
ization of two 
 
medial
 
 Golgi proteins GalNAcT2 and giantin
(Linstedt and Hauri, 1993) almost completely overlapped in
both control and COG3 KD-treated cells (Fig. 8 A, GalNacT2/
Giantin frames). And finally trans-Golgi localized p230 (Brown
et al., 2001) maintained its relative localization in COG3 KD
cells (Fig. 8 A, GalNacT2/p230 frames). We concluded that
Cog3p KD resulted in Golgi fragmentation into multiple mini-
Golgi stacks.
To confirm this conclusion the EM analysis of control
and COG3 KD cells (Fig. 8) was performed. We found that in
COG3 KD cells Golgi ribbon was disrupted onto multiple frag-
ments, comprising three to four stacked cisternae (Fig. 8 B, ii).
In addition to the Golgi fragments, a large number of 
 
 
 
60-nm
vesicles were observed in COG3 KD cells (Fig. 8 B, iii). Thus,
Cog3p depletion leads to both vesiculation of Golgi and break
up of the ribbon to multiple mini-stacks.
To test whether these Golgi mini-stacks can support
two basic Golgi functions, anterograde and retrograde proteins
flow, we used GFP-tagged vesicular stomatitis virus G protein
(VSVG) as a cargo marker for anterograde protein trafficking
(Suvorova et al., 2001) and Cy3-labeled subunit B of the Shiga
toxin (STB-Cy3) as a marker for the retrograde trafficking (Jo-
hannes et al., 1997).
2 d after siRNA treatment both control and COG3 KD
cells were transfected with the vector that directs synthesis of
the temperature-sensitive VSVG-GFP protein (Beckers et al.,
1987). VSVG was accumulated in the ER for 16 h at the re-
strictive temperature (39.5
 
 
 
C). After that cells were transferred
to the permissive temperature (32
 
 
 
C) to allow VSVG to travel
toward plasma membrane and fixed 2 h later. This time frame
is sufficient for VSVG delivery from the ER to PM in HeLa
cells (Suvorova et al., 2001). Indeed, we have observed that the
majority of both control and COG3 KD cells accumulated sig- 
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Figure 6.
 
Characterization of CCD vesicles.
 
 (A) Apparent release of GPP130-containing vesicles upon digitonin permeabilization. Control or COG3 KD
cells were either treated with buffer (
 
 
 
digitonin) or treated with 0.04 mg/ml digitonin, fixed, and analyzed by IF. Note that disperse vesicle-like staining
of GPP130 in COG3 KD cells was eliminated after digitonin treatment. Bars, 10 
 
 
 
l. (B) WB analysis of total cell lysates and subcellular fractions prepared
from COG3 KD and mock-treated HeLa cells. Cell lysates were fractionated on heavy membranes (P10) and light vesicle-containing fraction (S10). Equal
amount of protein (10 
 
 
 
g) was loaded per lane and analyzed by WB with antibodies to GPP130, GS28, syntaxin 5, and PDI. A portion of marker
proteins that was found in a vesicular fraction (
 
n 
 
  
 
2) was determined by semi-quantitative WB. (C) Separation of GPP130-containing membranes by gel
filtration. PNS from both control and COG3 KD cells was loaded on a Sephacryl S-1,000 column; 0.5-ml fractions were collected and analyzed by 
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nificant amounts of VSVG on the cell surface (Fig. 8 C,
merged images, arrowheads). Some VSVG was also found on
GS28-positive Golgi membranes in control cells and on Golgi
fragments in COG3 KD cells. In COG3 KD cells the major
pool of GS28 was localized on VSVG-negative CCD vesicles
(Fig. 8 C, inset).
Detailed analysis of 
 
 
 
200 VSVG-GFP-positive cells re-
vealed some minor trafficking defects and/or kinetic delays in
the ER-PM delivery of VSVG in COG3 KD cells (Fig. 8 D).
Significantly, more cells in a control group demonstrated com-
plete delivery of VSVG to the plasma membrane (22% vs. 6%
in COG3 KD cells) and twice as many cells in the COG3 KD
group accumulated VSVG in the ER (16% vs. 7% in COG3 KD
cells). Nevertheless, because the absolute majority (84%) of the
COG3 KD cells were able to deliver at least some VSVG mole-
cules to the cell surface, we concluded that fragmented Golgi is,
at least partially, competent to support anterograde protein traf-
ficking. This result is in agreement with previous findings
(Ram et al., 2002; Suvorova et al., 2002; Bruinsma et al., 2004)
that demonstrate the COG complex defects in yeast cells do not
interfere directly with the anterograde protein trafficking.
To investigate if Cog3p-depleted Golgi mini-stacks can
function in retrograde plasma membrane to ER protein traffick-
ing we have analyzed STB-Cy3 trafficking by using fluores-
cent live cell microscopy. In agreement with the data obtained
in many different labs (Sandvig et al., 1994; Johannes et al.,
1997) STB was rapidly internalized. In the majority of control
cells STB signal was detected in juxtanuclear region 2 h after
beginning of initial internalization (Fig. 8 E). In control cells
12 h later STB was entirely distributed between the ER and the
Golgi cisternae, marked by GalNAc-T2-GFP, (Fig. 8 F, control
row). In the COG3 KD cells, even at the 12 h time point, the
majority of internalized STB was localized in punctuate struc-
tures on cell periphery (Fig. 8 F, COG3 KD row). Some STB
was detected in a perinuclear region of transfected cells but
these STB-labeled membrane structures were clearly distinct
from the GalNAc-T2-GFP–containing Golgi fragments. None
of the STB was detected in the ER of COG3 KD cells (Fig. 8, E
and F, ER frames) indicating that retrograde trafficking through
the Cog3-depleted Golgi was blocked.
 
COG complex physically interacts with 
the Golgi SNARE molecules and the COP I 
vesicular coat
 
We have previously demonstrated that the yeast COG complex
regulates intra-Golgi retrograde trafficking and interacts with the
essential components of core machinery of vesicular Golgi traf-
fic, i.e., intra-Golgi SNARE proteins and COPI vesicular coat
(Suvorova et al., 2002). To test if the mammalian COG complex
may also interact with both SNARE and COPI components, we
isolated Golgi from the rat liver and performed an IP of the COG
complex, v-SNARE GS28, and PDI from detergent-solubi-
lized membranes. WB analysis of coIP proteins revealed that
both GS28 (
 
 
 
5% from total) and small amounts of t-SNARE
Syntaxin5 were coprecipitated with the Cog3p (Fig. 9 A, lane 1;
unpublished data). It was previously shown that Syntaxin5 and
GS28 form a Golgi-localized SNARE complex (Hay et al.,
1997) and our findings suggest that the COG complex can inter-
act with either individual SNARE proteins or with the entire
SNARE core complex. In the reciprocal precipitation, Cog3p
was coIP by anti-GS28 antibodies (Fig. 9 A, lane 4). Neither
Cog3p nor the Golgi SNARE molecules were precipitated with
control beads (Fig. 9 A, lane 3). We have also determined that
the 
 
 
 
 subunit of the COPI coat was specifically precipitated with
anti-Cog3p antibodies (Fig. 9 B, lane 2). These results indicated
that the mammalian COG complex like its yeast homologue
 
semi-quantitative WB. (D) Distribution of GPP130 and PDI on a velocity gradient. PNS from the COG3 KD cells was loaded on a 10–30% glycerol gradient.
GPP130 and PDI were analyzed in fractions by semi-quantitative WB. Fraction 1 corresponds to the top of the gradient. (E) Analysis of CCD vesicle fraction.
Fractions 3 and 4 from the glycerol gradient were concentrated by ultracentrifugation. Relative concentrations of Golgi and ER proteins were analyzed by
WB as described in Materials and methods. (F) CCD vesicles specifically bind to the COG complex in vitro. PNS from COG3 KD cells was incubated with
control beads, with beads loaded with the COG complex (COG), or with anti-GS15 IgGs (
 
 
 
-GS15). Precipitates were analyzed by WB with anti-GPP130
IgGs. (G) Accumulation of GalNAcT2 in CCD vesicles. Control or COG3 KD cells that stably express GalNAcT2-VSV were fixed and stained with mAbs
to GPP130 or polyclonal anti–VSV-tag and secondary antibodies conjugated with Alexa 594 (GalNAc-T2-VSV) or Alexa 488 (GPP130) as described in
Materials and methods. DNA was stained with DAPI. Images were acquired with 63
 
 
 
 objective and deconvolved. Double IF labeling revealed that the
vesicular pool of GalNAc-T2-VSV increased significantly in COG3 KD cells. Note that some vesicular profiles were double-labeled with both Golgi
markers (insets). Bar, 10 
 
 
 
m.
Figure 7. Accumulation of CCD vesicles precedes COG3 KD-induced
Golgi fragmentation. Control or COG3 KD cells that stably express GalT-
GFP were fixed 48 h after siRNA transfection and stained with anti-GS15
and secondary antibodies conjugated with Alexa 594. Images were
acquired with 63  objective and deconvolved. Note that the Golgi (arrows)
has not yet been fragmented in a subpopulation of the COG3 KD cells,
whereas the majority of GS15 was associated with multiple CCD vesicles.
Bar, 10  m. 
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Figure 8.
 
Golgi in COG3 KD cells is disrupted to mini-stacks, which are proficient in anterograde VSVG delivery to plasma membrane and defective in
retrograde trafficking of Shiga toxin B subunit.
 
 (A) Control and COG3 KD cells that stably express GalNAcT2-GFP were fixed and stained with anti-p115, anti-
giantin, or anti-p230 antibodies and secondary antibodies conjugated with Alexa 594. DNA was stained with DAPI. Images were acquired with 100
 
 
 
objective and deconvolved. Bar, 10 
 
 
 
m. (B) Ultrastructural analysis of Golgi in COG3 KD cells. Electron micrographs of the juxtanuclear region in control (i)
and COG3 KD (ii and iii) cells. Note the Golgi mini-stack in ii and multiple 60-nm vesicles in COG3 KD cells (ii and iii, arrows). G, Golgi; M, mitochondria;
N, nucleus; ER, endoplasmic reticulum. Bars, 1 
 
 
 
m. (C) Control and COG3 KD cells were transfected with the VSVG-GFP-ts045 vector. VSVG was accu-
mulated in the ER for 16 h at 39.5
 
 
 
C. After that cells were transferred to 32
 
 
 
C, incubated for 2 h, fixed, and processed for IF with anti-GS28 antibodies. 
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could physically interact with both vesicular and Golgi-localized
components of membrane transport machinery.
IF experiments indicated that CCD vesicles are distinct
from both ER (Fig. 9 D) and early endosomes (Fig. 9 E). To
test whether CCD vesicles are COPI-coated we performed dou-
ble-IF in COG3 KD VSVG-GFP expressing cells (Fig. 9 C). A
number of vesicle profiles were labeled with CCD vesicle
marker GS15 and some were colabeled with antibodies against
the epsilon subunit of COPI coat (Fig. 9 C, inset, arrowheads).
In contrast, VSVG was colocalized with the GS15 only on a
fragmented Golgi membrane (Fig. 9 C, inset, membranes
marked with an asterisk). These data indicated that CCD vesi-
cles do not carry anterograde cargo molecules and most likely
represent COPI-coated retrograde intra-Golgi vesicles that bud
from distal Golgi compartments and subsequently tether to the
cis-Golgi in a COG complex-dependent manner.
 
Discussion
 
Although both genetic and biochemical analysis indicated that
the COG complex primarily regulates retrograde intra-Golgi
membrane trafficking in budding yeast (Ram et al., 2002; Su-
vorova et al., 2002), the cellular role of the mammalian COG
complex is less clear. COG has been implicated in the antero-
grade intra-Golgi trafficking (Walter et al., 1998), ER to Golgi
protein delivery (Loh and Hong, 2002), glycoconjugate synthe-
sis, intracellular protein sorting, and protein secretion (Kings-
ley et al., 1986; Chatterton et al., 1999; Wu et al., 2004). The
most evolutionary conserved COG subunits bear 21–23% iden-
tity between yeasts and humans (Whyte and Munro, 2002).
Therefore, it is hard to make any functional predictions that are
simply based on protein similarities.
In this study, we report that the acute depletion of the
Cog3p subunit of the human COG complex results in accumu-
lation of nontethered transport vesicles, dramatic changes in
overall Golgi structure and block of Shiga toxin retrograde traf-
ficking. We have also obtained microscopic evidences that in
COG3 KD cells the fragmented Golgi maintains its cisternal
organization and that these Golgi mini-stacks are capable, at
least partially, to support anterograde protein delivery from the
ER to the plasma membrane. Finally, our data suggest that the
COG complex can directly interact with the CCD retrograde
vesicles via binding to both vesicular COPI coat and integral
components of vesicular SNARE machinery.
The COG3 KD differentially influences the protein level
of other COG subunits. Although the level of Cog1p, Cog2p,
and Cog4p is reduced more than twofold, the expression of the
other four subunits is not affected. Moreover Cog5-8p continue
to localize properly to membranes in a juxtanuclear region.
These data support our original model proposing two-lobed
COG complex structure (Ungar et al., 2002; Loh and Hong,
2004) and suggests that Lobe B (COGs 5–8) may be attached
to the Golgi membrane by its own receptor.
COG3 KD-induced Golgi fragmentation is specific and re-
versible because either simultaneous or subsequent introduction
of the mouse siRNA-insensitive version of the Cog3p is able to
restore a wild-type Golgi appearance. We have also demon-
strated that the disruption of the Golgi structure is observed in
cells microinjected with anti-Cog3p IgGs. The most likely ex-
planation of this phenomenon is that the antibody microinjection
induces the proteolytic degradation of the Cog3p similarly to the
recently described antibody-induced degradation of the Golgi
tethering factor p115 (Puthenveedu and Linstedt, 2001).
Observed Golgi fragmentation phenotype induced by the
COG3 KD is distinct from the Golgi appearance in 
 
 
 
COG1
 
and 
 
 
 
COG2
 
 CHO cells (Ungar et al., 2002) and indicate that
the acute COG3 KD, at least transiently, disrupts normal struc-
tural organization of the Golgi complex. In the majority of
COG3 KD cells fragmented Golgi membranes retain their jux-
tanuclear localization and their cisternal organization appear to
be normal both at the light microscopy and the EM levels. The
Golgi mini-stacks are capable to carry out a plasma membrane
delivery of VSVG, though with reduced efficiency compared
with a normal Golgi apparatus. This observation sharply differs
from the effect of p115 KD on VSVG trafficking (Puthenveedu
and Linstedt, 2004); it may reflect different roles of two
cis-Golgi localized tethering factors in membrane trafficking.
Moreover, in COG3 KD cells p115 is properly expressed (un-
published data) and its localization on the Golgi membranes is
virtually undisturbed. Only a small fraction of the COG3 KD
cells accumulates VSVG in the ER. These results agree with
our previous data that yeast COG mutants do not show any pri-
mary anterograde trafficking defects (Suvorova et al., 2002)
and that protein secretion in both 
 
 
 
COG1
 
 and 
 
 
 
COG2
 
 CHO
cells is not compromised (Kingsley et al., 1986).
Specific vesicle accumulation is a most striking pheno-
type observed after the COG3 KD. These CCD vesicles seem
to carry at least two different Golgi SNARE molecules, GS15
and GS28, and GPP130, a 130-kD, cis-Golgi protein that con-
tinuously cycle between the early Golgi and distal compart-
ments (Linstedt et al., 1997). Significantly, it has been shown
that these proteins are rapidly degraded in both 
 
 
 
COG1 and
 
 
 
COG2 CHO cells (Oka et al., 2004). The most likely expla-
nation is that after the acute COG3 KD, all three markers are
 
Both control and COG3 KD cells accumulated VSVG-GFP on the cell surface (merged images, arrows). Some VSVG was also found on GS28-positive Golgi
membranes in control cells and on juxtanuclear Golgi fragments in COG3 KD cells. The major pool of GS28 was localized on a VSVG-GFP-negative CCD ves-
icles in COG3 KD cells (inset). Bar, 10 
 
 
 
m. (D) 
 
 
 
100 cells in both control and COG3 KD samples were analyzed and each cell was assigned in specific group
bases on VSVG localization profile. PM, VSVG localized only on the plasma membrane; PM
 
 
 
Golgi, VSVG localized mostly on the plasma membrane, but par-
tially (
 
 
 
30%) on the Golgi; Golgi
 
 
 
PM, VSVG localized on the plasma membrane, but mostly on the Golgi; and ER
 
 
 
Golgi, accumulation of the VSVG in the
ER. All images were acquired with 63
 
 
 
 objective and deconvolved. (E) Retrograde trafficking of STB-Cy3. Control and COG3 KD cells that stably express GalT-
GFP were pulse incubated with the STB-Cy3 as described in Materials and methods and STB was allowed to internalize for 2 h. Cells were fixed and ER was
visualized with ER-Tracker. Note that majority of STB in control cells reached the Golgi (arrows), whereas in COG3 KD cells the STB-Cy3 signal was detected
only on cell periphery. Bars, 10 
 
 
 
m. (F) Same as in E, except GalNAc-T2-GFP HeLa cells were used and STB-Cy3 was internalized for 12 h. Bars, 10 
 
 
 
m. 
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transiently accumulated in nontethered recycling vesicles that
are rapidly degraded. We have found that 90 h after COG3 KD
the protein level of both GPP130 and GS28 was decreased (un-
published data). A number of Golgi resident proteins, includ-
ing MG160 (Johnston et al., 1994), GP73 (Puri et al., 2002),
GlcNAc T-1, and 
 
 
 
-1,2 mannosidase II (Opat et al., 2001a,b)
are shown to cycle through the trans-Golgi region. The predic-
tion is that in COG3 KD cells all these proteins will, at least
transiently, be accumulated in CCD vesicles.
What is the origin of CCD vesicles? IF data indicated that
the major pool of CCD vesicle is clearly distinct from both ER
and early endosomes. Some of CCD vesicles are likely to origi-
nate from the trans-Golgi because both GS28 and GS15 are
SNARE molecules that function in the intra-Golgi trafficking
(Xu et al., 2002; Volchuk et al., 2004). Alternatively, some CCD
vesicles could originate from TGN/sorting endosomal/recycling
compartments. GPP130 was shown to cycle through the trans-
Golgi/early endosomal membranes (Linstedt et al., 1997) and
both GS28 and GS15 could participate in the early endosomal
SNARE complex (Tai et al., 2004). Current models of Golgi traf-
ficking involving cisternal maturation (Pelham, 2001) predict that
all Golgi residents move down the stack to the late Golgi. Indeed,
a number of cis-Golgi residents in both yeast (Harris and Waters,
1996) and mammalian cells (Johnston et al., 1994; Bachert et al.,
2001; Opat et al., 2001a) have been shown to rapidly acquire spe-
cific modifications of the late Golgi. The rapid rate of trans-Golgi
modifications (Opat et al., 2001a) and relatively slow rate of the
recycling through the ER (Miles et al., 2001) suggest that cis- and
 
medial
 
-Golgi resident proteins are recycled directly from the
trans-Golgi and/or TGN to the corresponding early Golgi com-
partment. The COG complex localizes on 
 
cis/medial
 
 Golgi mem-
branes (Suvorova et al., 2001; Ungar et al., 2002) and most likely
regulates recycling of different resident Golgi proteins. We and
others have shown that mutations in y
 
COG3
 
 resulted in abnormal
Golgi recycling of yeast Golgi proteins Sec22p and Och1p
(Suvorova et al., 2002; Bruinsma et al., 2004).
Figure 9. The COG complex interacts with
retrograde Golgi SNARE GS28 and  -COPI.
(A and B) Protein complexes from detergent-
solubilized rat liver Golgi were IP using anti-
Cog3p (A, lane 1; B, lane 2), anti-GS28 (A,
lane 4), preimmune IgGs (A, lane 3), or anti-
PDI (B, lane 3). 10% of the Golgi lysates were
loaded as a control (A, lane 2; B, lane 1).
Note that Cog3p, GS28, and  -COPI were
not recovered with control beads or beads
loaded with anti-PDI antibodies (A, lane 3; B,
lane 3). (C) CCD vesicles are partially COPI
coated and do not carry VSVG. COG3 KD
cells that express VSVG-GFP were fixed and
processed for IF with mouse anti-GS15 anti-
bodies and rabbit anti– -COPI antibodies as
described in Materials and methods. All im-
ages were acquired with 63  objective and
deconvolved. Note that a number of GS15-
labeled CCD vesicles were colabeled with
antibodies to  -COPI coat (inset, arrowheads).
VSVG was partially colocalized with the
GS15 only on a fragmented Golgi membrane
(inset, membranes labeled with asterisk), but
not on CCD vesicles. Bar, 10  m. (D) CCD
vesicles do not significantly colocalize with the
ER. COG3 KD cells were fixed and stained
with rabbit anti-Sec61p (red) and mouse anti-
GS15 IgGs (green). Bar, 10  m. (E) CCD
vesicles are distinct from early endosomes.
COG3 KD cells were fixed and stained with
rabbit IgGs to GPP130 (red) and mouse anti-
EEA1 IgGs (green). Bar, 10  m. 
COG COMPLEX IN INTRA-GOLGI TRAFFICKING • ZOLOV AND LUPASHIN
 
757
 
CCD carriers are most likely to be formed in a COPI-
dependent reaction. COPI vesicles bud from all Golgi cisternae
and COPI is required for intra-Golgi transport in vitro (Orci et
al., 1997). In the in vitro assay, Golgi resident proteins man-
nosidase II and GS28, were found to be concentrated in COPI
vesicles (Lanoix et al., 1999, 2001), and these transport inter-
mediates were able to fuse with cis-Golgi compartment (Love
et al., 1998). The COG complex is a good candidate to orches-
trate COPI vesicle tethering. Indeed, genetic and biochemical
connections between yeast COG and COPI complexes (Ram et
al., 2002; Suvorova et al., 2002) have been shown. Oka et al.
(2004) reported recently that synthetic phenotypes arose in
mutants deficient in both epsilon-COPI and either COG1 or
COG2. During the investigation, we have found significant ac-
cumulation of COPI-positive vesicular profiles in COG3 KD
cells (unpublished data) and demonstrated that some of these
vesicles are double-labeled with the CCD vesicle cargo GS15.
Finally we have shown that the COG complex binds to CCD
vesicles in vitro and could be coIP with the 
 
 
 
-COPI.
In conclusion we propose a model (Fig. 10) in which the
cis-Golgi localized COG complex acts as a tether for retro-
grade COPI coated CCD vesicles that originate from distal
trans-Golgi/endosomal compartments. The acute COG3 KD
and corresponding defects in the Lobe A of the COG complex
discontinue normal vesicle recycling. Non-tethered vesicles
are transiently accumulated in cell cytoplasm as membrane-
depleted Golgi ribbon is fragmented in multiple Golgi mini-
stacks. Detailed biochemical analysis of CCD vesicles and the
elucidation of exact roles of both lobes of the COG complex
should help in our understanding of mechanisms of Golgi
maintenance and function.
 
Materials and methods
 
Reagents and antibodies
 
Most laboratory reagents were purchased from Sigma-Aldrich. Antibodies
used for WB and IF studies were obtained from standard commercial
sources and as gifts from generous individual investigators or generated
by us (see below). Antibodies (and their dilutions) were as follows: rabbit
pAbs: anti-Cog1 (Ungar et al., 2002), anti-Cog2p (Podos et al., 1994;
Ungar et al., 2002), anti-Cog3p (Suvorova et al., 2001), anti-Cog4p (Un-
gar et al., 2002), anti-Cog5p (Walter et al., 1998), anti-Cog6p, anti-
Cog7p, anti-Cog8p (Ungar et al., 2002), anti-GPP130 (Covance), anti-
giantin (a gift from A.D. Linstedt, Carnegie Mellon University, Pittsburgh,
PA), anti-p115 (a gift from M.G. Waters, Merck Research Laboratories,
Rahway, NJ), anti–
 
 
 
-COPI (a gift from R. Duden, Royal Holloway Univer-
sity of London, Egham, Surrey), rabbit pAb and monoclonal (18C8) anti-
syntaxin 5 (a gift from J. Hay, University of Michigan, Ann Arbor, MI),
anti–
 
 
 
-COPI (Sigma-Aldrich), anti-VSVG tag (E11; Delta Biolabs); murine
mAbs: anti-GPP130 (A1-118; a gift from A. Linstedt), anti-GM130 (BD
Biosciences), anti–GS-28 (BD Biosciences), anti-GS15 (BD Biosciences),
anti-p230 (BD Biosciences), and anti-PDI (Affinity BioReagents).
 
Mammalian cell culture, plasmids, and transfection
 
Monolayer HeLa cells were cultured in DME/F-12 media supplemented
with 15 mM Hepes, 2.5 mM 
 
L
 
-glutamine, 5% FBS, 100 U/ml penicillin G,
100 
 
 
 
g/ml streptomycin, and 0.25  g/ml amphotericin B. Cells were
grown at 37 C and 5% CO2 in a humidified chamber. HeLa cells that sta-
bly expressed GalNAc-T2 fused to GFP or to a VSV-tag and GalT fused
to GFP were provided by B. Storrie (University of Arkansas for Medical
Sciences, Little Rock, AR; Storrie et al., 1998). The plasmid encoding
VSVGtsO45-GFP was obtained from M.A. McNiven (Mayo Clinic, Roch-
ester, MN). The plasmid pYFP-hCOG3 was described previously (Su-
vorova et al., 2001). pCMV-SPORT6 with cDNA of mCOG3 (clone ID
4020725; NCBI Accession BC038030) was obtained from Invitrogen
and mCOG3 sequence was verified by sequencing. Transfections were
performed using TransIT-HeLaMONSTER Kit (Mirus Corporation).
RNA interference experiment
Human COG3 was targeted with a siRNA duplex (target sense, AGACT-
TGTGCAGTTTAACA). siRNAs were obtained as purified duplexes ob-
tained from Dharmacon Research. Transfection was performed using
Oligofectamine (Invitrogen) following the protocol recommended by Invi-
trogen. For WB, cells were plated in 24-well dishes, grown to a confluency
of  70%, transfected with siRNA for 24–72 h, and lysed in the SDS-
PAGE sample buffer.
IF microscopy
IF microscopy was performed using an epifluorescence microscope (Axio-
vert 200; Carl Zeiss Microimaging, Inc.) with a Plan-Apochromat 63  oil
immersion lens (NA 1.4) at RT. The secondary antibodies conjugated to
Alexa Fluor 488 or 594 were obtained from Molecular Probes, Inc. The
images were obtained using a QImaging Retiga Fast-EXi camera that was
controlled via IP Lab software. During the processing stage, individual im-
age channels were pseudocolored with RGB values corresponding to
each of the fluorophore emission spectral profiles. Images were cropped
using Adobe Photoshop software. Where indicated, images were digitally
deconvolved (Huygens Professional, Scientific Volume Imaging).
Live cell fluorescence microscopy
For live cell fluorescence microscopy, cells were cultured in Lab-TekII
Chambered Coverglass System (Nalge Nunc). Cells were maintained on
the microscope stage in a chamber at RT in DME/F12 without phenol red
and sodium pyruvate (Invitrogen).
For analysis of anterograde transports both COG3 KD and mock-
treated HeLa cells 60 h after siRNA treatment were transfected with a vec-
tor that encoded VSVGts045-GFP protein and were kept at the 39.5 C for
16 h (Suvorova et al., 2001). After that the temperature was reduced to
permissive one (32 C) to allow the VSVG to travel toward the plasma
membrane. After 2 h of chase, cells were fixed and stained for GS28.
For analysis of retrograde transport Cy3-Shiga toxin B subunit (STB-
Cy3; Mallard et al., 1998) was used. STB-Cy3 was a gift from B. Storrie.
60 h after the start of COG3 KD HeLa cells that stably express the Golgi
markers GalT-GFP or GalNacT2-GFP were incubated with STB-Cy3 for 30
min at 4 C, washed, refueled with fresh DME medium without phenol red,
and incubated for 2 or 12 h at 37 C and 5% CO2 in a humidified cham-
ber. ER was visualized with the ER-Tracker blue-white PDX (Molecular
Probes). Images were obtained as described above.
EM
Cells were fixed with 3% glutaraldehyde in PBS for 2 h at 4 C. Cells were
washed three times with PBS, fixed with 2% OsO4 in PBS, washed again,
Figure 10. Model for the COG complex function in membrane trafficking.
Cis-Golgi localized COG complex acts a tether for retrograde COPI-
coated CCD vesicles that originate from the trans-Golgi/endosomal com-
partment(s). The COG3 KD abolishes vesicle tethering to the cis-Golgi. As
a result multiple nontethered vesicles are transiently accumulated in cell
cytoplasm and the membrane-depleted Golgi ribbon is fragmented into
multiple Golgi mini-stacks.JCB • VOLUME 168 • NUMBER 5 • 2005 758
dehydrated in a graded ethanol series, and embedded in Epon 812. Ul-
trathin sections were obtained using RMC MT-7000 microtome, double
stained with uranyl acetate and lead citrate. Specimens were examined
using JEOL JEM-1010 electron microscope at 80 kV with magnification
ranging from 15,000 to 75,000 .
Microinjection of anti-COG3 antibodies
HeLa cells that stably expressed GalT-GFP were microinjected with anti-
Cog3p IgGs with the Narishigee Micromanipulator and imaged imme-
diately and 4 h after the injection using a 40 , 1.3 NA Fluor objective
fitted to a confocal microscope (model LSM410; Carl Zeiss MicroImag-
ing, Inc.). The antibody concentration was 2 mg/ml, Texas red was
used as an injection marker. Microinjection of the preimmune IgGs was
used as the control.
Cell fractionation and preparation of CCD vesicles
HeLa cells were cultured to  80% confluence in 60-mm dishes and trans-
fected with COG3 siRNA. 78 h after transfection (KD efficiency of
Cog3p   80%), cells were washed three times with PBS and then
scraped in 0.3 ml of 20 mM Hepes-KOH buffer, pH 7.4, supplemented
with a proteinase inhibitor cocktail (Roche Diagnostics Corporation) on
ice. The cells were disrupted using a Potter homogenizer. Subcellular
fractions were obtained by standard differential centrifugation. The PNS
was obtained at 500 g (5 min, 3 C). Heavy membranes, including ER
and the Golgi were pelleted at 10,000 g (10 min, 3 C). Light mem-
branes, including transport vesicle were obtained by centrifugation con-
ducted in a rotor (model TLA-100; Beckman Coulter) at 100,000 g (1 h,
3 C). All membrane pellets were resuspended in 2% SDS in volumes
equal to volume of original lysate. Membrane and cytoplasmic proteins
were denatured by heating at 95 C for 5 min. To normalize the sample
loading for WB analysis, protein content was measured using the BCA
reagent (Pierce Chemical Co.).
Glycerol velocity centrifugation and gel filtration
Gradient fractionation was prepared as described previously (Jesch and
Linstedt, 1998) with some modification. To prepare the lysate, 72 h
COG3 KD HeLa cells from one 10-cm plate were collected by trypsiniza-
tion, pelleted (500 g for 5 min), then washed once in PBS, and once in
STE buffer (250 mM sucrose, 10 mM triethylamine, pH 7.4, 1 mM EDTA,
with protease inhibitors), homogenized by 20 passages through a 25-
gauge needle in 0.5-ml buffer STE without sucrose, and then centrifuged
at 1,000 g for 2 min to obtain PNS. This supernatant was used for both
gradient fractionation and gel filtration. PNS (1 ml) was layered on linear
10–30% (wt/vol) glycerol gradients (12 ml in 10 mM triethylamine, pH
7.4, and 1 mM EDTA on a 0.5 ml 80% sucrose cushion) and centrifuged
at 280,000 g for 60 min in a SW40 Ti rotor (Beckman Coulter).
1 ml fractions were collected from the top. All steps were performed
at 4 C. 50  l of each fraction was combined with sample buffer, then
loaded on SDS-PAGE and analyzed by WB.
For gel filtration analysis, PNS was loaded onto 29   0.7 cm
Sephacryl S-1000 gel filtration column. Material was eluted in STE buffer at
flow rate of 0.3 ml/h. 0.5-ml fractions were collected and analyzed by WB.
Interaction of the COG complex with CCD vesicles
The COG complex was isolated from HeLa cells that express YFP-Cog3p
(Suvorova et al., 2001). Cells from two 10-cm plates were homogenized
in equal volumes of cold CTN buffer (2% CHAPS, 40 mM Tris-HCl, pH
7.4, 300 mM NaCl, protease inhibitor cocktail) on ice. Cell lysates were
clarified by centrifugation at 20,000 g for 10 min. The supernatant was
transferred into a new presiliconized tube, diluted twice with TBST (TBS
with 0.05% Tween 20), and incubated with 50  l of protein A Sepharose
CL-4B (Amersham Biosciences) on a tube rotator for 30 min, then beads
were sedimented at 500 g (1 min, 3 C). The supernatant was transferred
in a new tube, 2  g of anti-GFP antibodies were added, and the tube was
incubated on the tube rotator for 4 h in a cold room. After that 30  l of
protein G–Agarose beads were added to the samples and incubated for
1 h. Beads were sedimented by centrifugation at 110 g for 1 min and
washed four times with TBST. The COG complex-loaded beads were
transferred to a new tube, washed again and finally resuspended in 60  l
of TBST. 20  l of beads were tested for the presence of YFP-Cog3p and
other COG subunits by WB.
40  l of COG complex beads were incubated for 4 h with the
CCD vesicles enriched supernatant from the COG3 KD cells. Beads were
washed three times and eluted with the sample buffer. Similar Incubation
with untreated protein G–agarose beads or protein G–agarose beads pre-
loaded with anti-GS15 antibodies was used as a control.
IP experiments using rat liver Golgi membranes
Rat liver Golgi membranes were purified as described by Hamilton et al.
(1991) and frozen in aliquots in liquid nitrogen. All of the following oper-
ations were performed in a cold room. Membranes were thawed on ice
in an equal volume of cold CTN buffer and incubated for 30 min. 50  l
of protein A Sepharose in TBS was added and incubated on a tube rota-
tor for 30 min. Insoluble material and beads were pelleted at 20,000 g
for 10 min at 3 C. The supernatant was transferred to a new tube and di-
luted twice with TBST. 2  g of anti-Cog3p, anti-GS28 or anti-PDI antibod-
ies were added to the diluted samples and incubated on tube rotator for
4 h. 20  l of protein G agarose were added to the samples and incu-
bated for another hour. After incubation the beads were sedimented by
low speed centrifugation at 110 g for 1 min and washed four times with
TBST. After that beads were transferred to a new tube, resuspended in 30
 l of 2  sample buffer, heated for 5 min at 95 C, loaded on SDS-PAGE,
and analyzed by WB.
SDS-PAGE and Western blotting
SDS-PAGE and WB were performed as described by Suvorova et al.
(2002). A signal was detected using a chemiluminescence reagent kit
(PerkinElmer Life Sciences) and quantitated using ImageJ software (http://
rsb.info.nih.gov/ij/).
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